Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.18 per share which missed the analyst consensus estimate of $84.03 by 99.79 percent. This is a 14.29 percent decrease over earnings of $0.21 per share from the same period last year. The company reported quarterly sales of $957.00 million which missed the analyst consensus estimate of $76.49 billion by 98.75 percent. This is a 16.57 percent increase over sales of $821.00 million the same period last year.